BioCentury
ARTICLE | Company News

Glenmark opens first U.S. manufacturing site

November 2, 2018 8:02 PM UTC

Indian company Glenmark Pharmaceuticals Ltd. (NSE:GLENMARK; BSE:532296) opened its first U.S. manufacturing site in Monroe, N.C. The company invested $100 million in the site, which has 168 employees and will produce fixed-dose pharmaceutical formulations...

BCIQ Company Profiles

Glenmark Pharmaceuticals Ltd.